KASID
Current Issue Volume 23(1); January 2025
Intestinal Research
Latest Issue: Volume 23 Issue 1
Editor-in-Chief: Toshifumi Hibi
Print ISSN: 1598-9100
Online ISSN: 2288-1956
Online ISSN: 2288-1956
Frequency: Quarterly
Impact Factor: 3.4
Gastroenterology & Hepatology - Q2 (44/143)
Impact Factor: 3.4
Gastroenterology & Hepatology - Q2 (44/143)
, Daryl W. T. Tang
, Sunny H. Wong
, Ishaan Dharia
, Danujan Sriranganathan
, et al.
, Axel Dignass
, Xavier Roblin
, et al.
, Chi-Hsiang Chung
, Daniele Piovani
- MOST CITED
-
- Korean clinical practice guidelines on biologics and small molecules for moderate-to-severe ulcerative colitis34
- Korean clinical practice guidelines on biologics for moderate to severe Crohn’s disease27
- Animal models of inflammatory bowel disease: novel experiments for revealing pathogenesis of colitis, fibrosis, and colitis-associated colon cancer19
- Gut microbiota in pathophysiology, diagnosis, and therapeutics of inflammatory bowel disease15
- MOST VIEWED
-
- Korean clinical practice guidelines on biologics and small molecules for moderate-to-severe ulcerative colitis9,816
- Gut microbiota in pathophysiology, diagnosis, and therapeutics of inflammatory bowel disease8,959
- Korean Guidelines for Postpolypectomy Colonoscopic Surveillance: 2022 revised edition8,420
- Use of device-assisted enteroscopy in small bowel disease: an expert consensus statement by the Korean Association for the Study of Intestinal Diseases7,792
- AHEAD OF PRINT
-
- Burden of inflammatory bowel disease in India: analysis of the Global Burden of Disease study from 1990 to 2019
- Propensity score-matched real-world comparative treatment outcomes of Janus kinase inhibitors for ulcerative colitis in patients with and without prior exposure to anti-tumor necrosis factor α antibody
- Short-term and long-term outcomes of acute severe ulcerative colitis in Taiwan: a multicenter study with pre- and post-biologics comparison
- Real-world use of biologics during the first year of treatment for newly diagnosed Crohn’s disease in Japan: a claims analysis from 2010 to 2021
